Discussing Asensus Surgical’s Senhance Robotic Surgical System

Discussing Asensus Surgical’s Senhance Robotic Surgical System

MPO's Sean Fenske speaks with Anthony Fernando of Asensus Surgical about what makes his company’s robotic surgical system unique.

By Sean Fenske, Editor-in-Chief06.17.21
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Anthony Fernando, the president and CEO of Asensus Surgical. He talks about his company’s Senhance robotic surgical system and how it stands apart from competitors. In addition, he discusses the integration of artificial intelligence and machine learning within robotic surgical technologies. Specifically, the following questions are addressed.

  • Your company offers the Senhance Surgical System. Can you tell me what that is?
  • We’re seeing an emergence of robotic surgical systems in healthcare. What differentiates the Senhance System?
  • What role is AI and machine learning playing in robotic surgical systems?
  • I mentioned the emergence of robotic surgical solutions we are seeing. Why is that? What’s driving this segment?
  • What’s ahead for robotic surgical systems? Where is this sector headed in five years?

Listen to this episode and see what you think of the Senhance system. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.
Related Searches: